Skip to main content
Figure 6 | Trials

Figure 6

From: Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation

Figure 6

Internal company emails illustrating decisions to delay publication of trial findings from Study 224 that were not statistically significant. Excerpts from multiple internal company emails, chronologically arranged, illustrating the decision to delay publication of results from Study 945–224 with statistically non-significant findings. Individuals’ names have been redacted by us such that only first initials can be seen. Excerpted from Pfizer_LCastro_002679 [34], Pfizer_LCastro_002680 [34], Pfizer_LeslieTive_0020985 [37], Pfizer_LeslieTive_0020922 [38], Pfizer_JMarino_0000809 [39], and FAL007964 [35].

Back to article page